Skip to main content
Erminia Massarelli, MD, Hematology, Bradbury, CA

ErminiaMassarelliMD

Hematology Bradbury, CA

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Massarelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Massarelli's full profile

Already have an account?

  • Office

    1500 Duarte Rd
    Bradbury, CA 91010
    Phone+1 713-792-6161

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
  • Methodist Hospital (Houston)
    Methodist Hospital (Houston)Residency, Internal Medicine, 2007 - 2009
  • University of Naples Faculty of Medicine
    University of Naples Faculty of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • TX State Medical License
    TX State Medical License 2012 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16–Related Cancer  
    Erminia Massarelli, William William, Ming Guo, Merrill Kies, Bonnie Glisson, Hai Tran, Faye Johnson, Renata Ferrarotto, Lei Feng, JAMA

Press Mentions

  • Business Digest: UT Health Expands Services in Tyler
    Business Digest: UT Health Expands Services in TylerSeptember 10th, 2024
  • City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated Cancers
    City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated CancersAugust 15th, 2019
  • Expert Discusses Treatment Advances in ALK-Positive NSCLC
    Expert Discusses Treatment Advances in ALK-Positive NSCLCJanuary 9th, 2018
  • Join now to see all